Page 133 - Read Online

Calvo et al. Omega-3 fatty acids in cardiovascular health

2013;75:645-62. Lagarde M, Guichardant M. Protectin DX, a double lipoxygenase
41. Puglisi MJ, Hasty AH, Saraswathi V. The role of adipose tissue in product of DHA, inhibits both ROS production in human neutrophils
mediating the beneficial effects of dietary fish oil. J Nutr Biochem and cyclooxygenase activities. Lipids 2014;49:49-57.
2011;22:101-8. 61. Lagarde M, Calzada C, Guichardant M, Véricel E. Dose-effect and
42. Nakahira K, Kim HP, Geng XH, Nakao A, Wang X, Murase N, Borghi metabolism of docosahexaenoic acid. Pathophysiological relevance in
C. Carbon monoxide differentially inhibits TLR signaling pathways blood platelets. Prostaglandins Leukot Essent Fatty Acids 2013;88:49-
by regulating ROS-induced trafficking of TLRs to lipid rafts. J Exp 52.
Med 2006;203:2377-89. 62. Leray C, Wiesel ML, Freund M, Cazenave JP, Gachet C. Long-chain
43. Rockett BD, Salameh M, Carraway K, Morrison K, Shaikh SR. n-3 n-3 fatty acids specifically affect rat coagulation factors dependent on
PUFA improves fatty acid composition, prevents palmitate-induced vitamin K. Arterioscler Thromb Vasc Biol 2001;21:459-65.
apoptosis, and differentially modifies B cell cytokine secretion in vitro 63. Vanschoonbeek K, Wouters K, van der Meijden PE, van Gorp
and ex vivo. J Lipid Res 2010;51:1284-97. PJ, Feijge MA, Herfs M, Schurgers LJ, Hofker MH, de Maat
44. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, Li P, MP, Heemskerk JW. Anticoagulant effect of dietary fish oil in
Lu WJ, Watkins SM, Olefsky JM. GPR120 is an omega-3 fatty acid hyperlipidemia: a study of hepatic gene expression in APOE2 knock-
receptor mediating potent anti-inflammatory and insulin-sensitizing in mice. Arterioscler Thromb Vasc Biol 2008;28:2023-9.
effects. Cell 2010;142:687-98. 64. Vanschoonbeek K, Feijge MA, Paquay M, Rosing J, Saris W, Kluft
45. Oh DY, Walenta E. The role of omega-3 fatty acid receptor GPR120 C, Giesen PL, de Maat MP, Heemskerk JW. Variable hypocoagulant
in insulin resistance. Int J Obes Suppl 2014;4:S14-6. effect of fish oil intake in humans: modulation of fibrinogen level and
46. Oh DY, Walenta E. Omega-3 fatty acids and FFAR4. Front thrombin generation. Arterioscler Thromb Vasc Biol 2004;24:1734-
Endocrinol (Lausanne) 2014;5:115. 40.
47. Stulnig TM, Huber J, Leitinger N, Imre EM, Angelisova P, Nowotny 65. Finnegan YE, Howarth D, Minihane AM, Kew S, Miller GJ, Calder
P, Waldhausl W. Polyunsaturated eicosapentaenoic acid displaces PC, Williams CM. Plant and marine derived (n-3) polyunsaturated
proteins from membrane rafts by altering raft lipid composition. J Biol fatty acids do not affect blood coagulation and fibrinolytic factors in
Chem 2001;276:37335-40. moderately hyperlipidemic humans. J Nutr 2003;133:2210-3.
48. Bang HO, Dyerberg J. Lipid metabolism and ischemic heart disease 66. Montegaard C, Tulk HM, Lauritzen L, Tholstrup T, Robinson LE.
in Greenland Eskimos. In: Draper HH, editor. Advances in Nutritional Acute ingestion of long-chain (n-3) polyunsaturated fatty acids
Research. New York, NY: Plenum Press; 1980. p. 1-22. decreases fibrinolysis in men with metabolic syndrome. J Nutr
49. Dyerberg J, Bang HO. Haemostatic function and platelet 2010;140:38-43.
polyunsaturated fatty acids in Eskimos. Lancet 1979;2:433-5. 67. Bang HO, Dyerberg J. Plasma lipids and lipoproteins in Greenlandic
50. Bang HO, Dyerberg J. The bleeding tendency in Eskimos. Dan Med west coast Eskimos. Acta Med Scand 1972;192:85-94.
Bull 1980;27:202-5. 68. Dyerberg J, Bang HO, Hjorne N. Plasma cholesterol concentration in
51. Larson MK, Tormoen GW, Weaver LJ, Luepke KJ, Patel IA, Hjelmen Caucasian Danes and Greenland west coast Eskimos. Dan Med Bull
CE. Exogenous modification of platelet membranes with the omega-3 1977;24:52-5.
fatty acids EPA and DHA reduces platelet procoagulant activity and 69. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J.
thrombus formation. Am J Physiol Cell Physiol 2013;304:C273-9. Effects of omega-3 fatty acids on serum markers of cardiovascular
52. von Schacky C, Siess W, Fischer S, Weber PC. A comparative study disease risk: a systematic review. Atherosclerosis 2006;189:19-30.
of eicosapentaenoic acid metabolism by human platelets in vivo and 70. Balk E, Chung M, Lichtenstein A, Chew P, Kupelnick B, Lawrence
in vitro. J Lipid Res 1985;26:457-64. A, DeVine D, Lau J. Effects of omega-3 fatty acids on cardiovascular
53. Hirai A, Hamazaki T, Terano T, Nishikawa T, Tamura Y, Kamugai risk factors and intermediate markers of cardiovascular disease. Evid
A, Jajiki J. Eicosapentaenoic acid and platelet function in Japanese. Rep Technol Assess (Summ) 2004;(93):1-6.
Lancet 1980;2:1132-3. 71. Kelley DS, Siegel D, Vemuri M, Mackey BE. Docosahexaenoic acid
54. Mohebi-Nejad A, Bikdeli B. Omega-3 supplements and cardiovascular supplementation improves fasting and postprandial lipid profiles in
diseases. Tanaffos 2014;13:6-14. hypertriglyceridemic men. Am J Clin Nutr 2007;86:324-33.
55. Lagarde M, Calzada C, Guichardant M, Vericel E. In vitro and in 72. Harris WS, Bulchandani D. Why do omega3 fatty acids lower serum
vivo bimodal effects of docosahexaenoic acid supplements on redox triglycerids? Curr Opin Lipidol 2006;17:387-93.
status and platelet function. Prostaglandins Leukot Essent Fatty Acids 73. Tillander V, Bjørndal B, Burri L, Bohov P, Skorve J, Berge RK,
2016;108:1-4. Alexson SE. Fish oil and krill oil supplementations differentially
56. Phang M, Lincz LF, Garg ML. Eicosapentaenoic and docosahexaenoic regulate lipid catabolic and synthetic pathways in mice. Nutr Metab
acid supplementations reduce platelet aggregation and hemostatic (Lond) 2014;11:20.
markers differentially in men and women. J Nutr 2013;143:457-63. 74. Walczak R, Tontonoz P. PPARadigms and PPARadoxes: expanding
57. Walker CG, West AL, Browning LM, Madden J, Gambell JM, Jebb rolesfor PPARg in the control of lipid metabolism. J Lipid Res
SA, Calder PC. The pattern of fatty acids displaced by EPA and DHA 2002;43:177-86.
following 12 months supplementation varies between blood cell and 75. Shao W, Espenshade PJ. Expanding roles for SREBP in metabolism.
plasma fractions. Nutrients 2015;7:6281-93. Cell Metab 2012;16:414-9.
58. Ayala J, Lopez C, Azueg H, Oberto C, Paiva A, Lares M. Effects 76. Landa V, Zídek V, Mlejnek P, Šimáková M, Šilhavý J, Trnovská J,
of polyunsaturated fatty acids (omega-3) on the platelet aggregation. Kazdová L, Pravenec M. Sterol regulatory element binding protein 2
Rev Latinoam Hiperte 2009;4:71-8. (in Portuguese) overexpression is associated with reduced adipogenesis and ectopic
59. Parent CA, Lagarde M, Venton DL, Le Breton GC. Selective fat accumulation in transgenic spontaneously hypertensive rats.
modulation of the human platelet thromboxane A2/prostaglandin Physiol Res 2014;63:587-90.
H2 receptor by eicosapentaenoic and docosahexaenoic acids in 77. Yang T, Espenshade PJ, Wright ME, Yabe D, Gong Y, Aebersold
intact platelets and solubilized platelet membranes. J Biol Chem R, Goldstein JL, Brown MS. Crucial step in cholesterol homeostasis:
1992;267:6541-7. sterols promote binding of SCAP to INSIG-1, a membrane protein
60. Liu M, Boussetta T, Makni-Maalej K, Fay M, Driss F, El-Benna J, that facilitates retention of SREBPs in ER. Cell 2002;110:489-500.
126 Vessel Plus ¦ Volume 1 ¦ September 26, 2017